Featured Research

from universities, journals, and other organizations

Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years

Date:
May 15, 2008
Source:
American Urological Association
Summary:
Premalignant phases of prostate cancer occur over long periods of time and a single prostate-specific antigen reading taken at age 44-50 can help predict prostate cancer diagnosis up to 30 years subsequently, according to updated data from researchers in New York and Malmo, Sweden. The findings expand the previously established baseline age-to-diagnosis interval.

Premalignant phases of prostate cancer occur over long periods of time and a single prostate-specific antigen (PSA) reading taken at age 44-50 can help predict prostate cancer diagnosis up to 30 years subsequently, according to updated data from researchers in New York and Malmo, Sweden.

The findings expand the previously established baseline age-to-diagnosis interval.

Using data from a cohort of men under 50 who submitted blood samples for a cardiovascular study during 1974-1986, researchers examined records and found a greater delay in diagnosis for men who were younger at the time of the blood draw and baseline reading.

Men in the original cohort had a mean age of 47 at the time of the blood draw. In this update, the mean age was 45.

The relationship between PSA and advanced cancer was stronger in this update than the original report.

Findings suggest possible prolonged periods of prostate cancer pre-malignancy and that extracellular PSA affects cancer development, or carcinogenesis. The study also reaffirms the relationship between the carcinogenic process and PSA.


Story Source:

The above story is based on materials provided by American Urological Association. Note: Materials may be edited for content and length.


Journal Reference:

  1. Lilja H, Cronin AM, Scardino PT, Dahlin A, Bjartel A, Berglund G et al: A single PSA predicts prostate cancer up to 30 years subsequently, even in men below age 40. J Urol, suppl., 2008; 179: 206, abstract 589. [link]

Cite This Page:

American Urological Association. "Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years." ScienceDaily. ScienceDaily, 15 May 2008. <www.sciencedaily.com/releases/2008/05/080515072855.htm>.
American Urological Association. (2008, May 15). Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2008/05/080515072855.htm
American Urological Association. "Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years." ScienceDaily. www.sciencedaily.com/releases/2008/05/080515072855.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins